The effect of two different oxytetracycline treatments in experimental Ehrlichia phagocytophila infected lambs

The effect of 2 different oxytetracycline treatments in acute E. phagocytophila infected lambs was investigated. Twenty 5-month-old lambs of the Dala and Rygja breeds were used. Ten lambs were inoculated intravenously with a stabilate of an ovine E. phagocytophila strain. On the third day of fever, 4 lambs were given long-acting oxytetracycline (Terramycin prolongatum vet, Pfizer) (20 mg/kg) intramuscularly and another 4 lambs were given short-acting oxytetracycline (Terramycin vet, Pfizer) (10 mg/kg) intravenously for 5 consecutive days. The lambs were examined for the presence of Ehrlichia infection by blood smear evaluation, polymerase chain reaction (PCR) and antibody titre against E. equi. One month after the last antibiotic treatment, 250 ml citrate blood from each of these lambs were inoculated into each of 10 susceptible lambs, which were observed during the following 6 weeks. The results indicate that oxytetracycline given in the acute stage of the infection may effectively terminate the development of fever, rickettsemia and weight reduction in E. phagocytophila infected lambs. No difference was observed between the 2 treatment groups. However, at least 3 of 8 antibiotic treated lambs (37.5%) were still infected with granulocytic Ehrlichia 3 months after treatment.     

Curative effect of autologous platelet-rich plasma on a large cutaneous lesion in a dog

A dorsal tail mass (1 × 1.2 cm) was observed on a 10-year-old castrated male, Shih-tzu dog. A biopsy of the mass was performed and diagnosed histopathologically as a follicular cyst. A necrotic lesion (2.5 × 3 cm) developed at the biopsy site 1 week after sampling and failed to respond to 2 weeks of normal saline cleansing and systemic antibiotic administration. Autologous platelet-rich plasma was applied to the lesion which gradually improved over a 4-week period possibly by a contribution to the secretion of growth hormone, which can accelerate tissue regeneration. This case report suggests that autologous PRP may be beneficial in the management of large skin defects or in delayed wound healing.     

Use of mucosal grafts and temporary tube implants for treatment of teat sinus mucosal injuries

A mucosal lesion was created in the center of each test sinus of 6 mature, healthy, nonlactating Holstein cows by resecting a circumferential band of mucosa. Each lesion was then treated by implantation of strip grafts of autogenous oral mucosa, temporary silastic tube implant, or a combination of strip grafts and temporary silastic tube implant. All teats were evaluated for patency 6 weeks after treatment, and tube implants were removed through a second thelotomy incision. All teats were reevaluated for gross and radiographic patency 12 weeks after treatment, and teats were collected for histologic evaluation of lesions. All 4 teats treated with grafts only were obstructed at 6 and 12 weeks after treatment. Incomplete coverage of the lesion with mucosa was observed in all 4 teats. The major source of obstruction was proliferation of epithelium and keratin into the lumen. All 8 teats treated with temporary silastic tube implants alone were patent at 6 weeks after treatment, but were obstructed at 12 weeks after treatment. Foci of mucosa at the lesion site were detected in only 2 of the 8 teats. Obstruction resulted from proliferation of granulation tissue into the lumen. All 12 teats treated with grafts and a temporary tube implant were patent at 6 weeks after treatment and 11 of 12 were patent at 12 weeks after treatment, although marked luminal narrowing was evident in 9 of 11 teats. Partial to complete coverage of the lesion with mucosa was seen in all teats. Proliferative granulation tissue, epithelium, and keratin contributed to luminal narrowing in 10 of 11 patent teats. Bacteriologic culture of quarters from 6 of the 11 teats patent at the final evaluation yielded pathogens.     

TOLERABILITY AND TUMOR RESPONSE OF A NOVEL LOW‐DOSE PALLIATIVE RADIATION THERAPY PROTOCOL IN DOGS WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER AND URETHRA

Previously reported radiation protocols for transitional cell carcinoma of the canine lower urinary tract have been ineffective or associated with increased side effects. Objectives of this retrospective, cross‐sectional study were to describe safety of and tumor responses for a novel palliative radiation protocol for transitional cell carcinoma in dogs. Included dogs had cytologically or histologically confirmed transitional cell carcinoma of the bladder or urethra, and were treated with 10 once‐daily fractions (Monday–Friday) of 2.7 Gy. Thirteen dogs were sampled, with six treated using radiation as first‐line (induction) therapy and seven treated using radiation as rescue therapy after failing previous chemotherapy. Within 6 weeks of radiation, 7.6% (1/13) dogs had a complete response, 53.8% (7/13) partial response, 38.5% (5/13) stable disease, and none had progressive disease. Three patients presenting with urethral obstruction had spontaneous micturition restored during the treatment protocol. A single patient with unilateral ureteral obstruction was patent at recheck examination. Median survival time from time of initial diagnosis was 179 days. Median survival time from start of radiation was 150 days. Acute radiation side effects occurred in 31% (4/13) patients and were classified as grade 1 or 2. No significant late side radiation side effects were reported. No variables examined were identified as prognostic factors. Findings indicated that the reported radiation protocol was safe in this sample of dogs with bladder and urethral transitional cell carcinoma. Future prospective studies are needed to determine utility of this treatment as a rescue therapy in patients with complete urinary tract obstruction.     

Toxic peripheral neuropathy with demyelination in Sprague-Dawley rats given CGS 21595--a 5-lipoxygenase inhibitor.

Male and female Sprague-Dawley rats were given CGS 21595, a pro-drug that is almost immediately metabolized to CGS 19213, a naphthoquinone that acts as a 5-lipoxygenase inhibitor. The compound was administered by gavage to five groups of Sprague-Dawley rats (group Nos. 1, 5, n = 30; group Nos. 2-4, n = 20) at daily doses of 0, 50, 150, 500, or 1,000 mg/kg for 13 weeks. Rats in the higher dose groups had a reduced weight gain, but significant neurologic signs were not observed. A peripheral neuropathy consisting predominantly of myelin destruction in the spinal nerve roots and sciatic nerves in male rats treated with greater than or equal to 150 mg/kg CGS 21595 and in female rats treated with greater than or equal to 50 mg/kg CGS 21595 for 13 weeks. This lesion was not fully reversible after a recovery period of 4 weeks. Lesions consisted of ballooning of myelin sheaths, infiltration by macrophages, demyelination, and occasional areas of remyelination. Axons were generally preserved, and the brain and spinal cord were not affected. Male and female rats in all treatment groups had cytoplasmic hyaline droplets in the proximal renal tubules. This change was reversible after 4 weeks and was not associated with any other adverse effects on the kidney.     

一株H5N6亚型禽流感病毒对鸭和小鼠的致病性研究

为了研究一株从鹭中分离到的禽流感病毒(AIV)A/Heron/Guangdong/C1/2013(H5N6)对鸭和小鼠的致病力,本研究通过对鸭和小鼠滴鼻点眼和鸡的颈静脉注射进行攻毒试验,观察其致病力和组织病理学等变化,对其生物学特性进行初步研究。结果显示,该毒株的鸡胚半数感染量(EID₅₀)为10^-8.16/0.1 mL,静脉接种致病指数(IVPI)为2.76。对鸭的半数致死量(LD₅₀)为10^-4.0/0.2 mL,对小鼠的LD₅₀为10^-4.67/0.05 mL。以10⁶ EID₅₀/只滴鼻点眼感染鸭,主要表现为食欲下降、精神萎靡、肿头流泪等症状,大多数鸭在感染后4~7 d死亡,感染后第7 天肝脏、肺脏、肾脏仍在排毒,解剖可见心包积液、肺脏淤血、肾脏肿大等症状,病理切片可见心脏、肝脏、脾脏、肾脏炎性细胞浸润,脑细胞核固缩等病变。以5×10⁵ EID₅₀/只滴鼻感染小鼠,主要表现为食欲下降、精神萎靡、被毛粗乱、聚堆等症状,大部分小鼠在感染后5~7 d死亡,第7天时只有肺脏仍在排毒,各脏器解剖学病变不明显,病理切片可见心脏、肾脏、肺脏炎性细胞浸润,脑细胞核固缩等病变。研究结果表明,该H5N6亚型AIV毒株对鸭和小鼠具有很强的致病力,IVPI大于1.2,为高致病性AIV,本研究为H5N6亚型AIV研究和防控提供了理论基础。     

泰地罗新研究进展

概述了泰地罗新的理化性质、作用机理、抗菌活性、药动学、药效学、不良反应及残留,以期为该药在兽医临床的应用提供参考资料。泰地罗新是动物专用的新型大环内酯类抗生素,其吸收快,达峰时间短,生物利用度高,肺组织浓度高,消除半衰期长,药效持久。单次肌注或皮下注射给药,即能提供全程治疗,在兽医临床具有广阔的应用前景。     

Effects of tylosin feeding on the antibiotic resistance of selected gram-positive bacteria in pigs

The effect of tylosin on macrolide resistance of gram-positive bacteria of pigs was determined. After an initial base-line period during which the pigs were given antibiotic-free feed, 1 group of 8 pigs was given tylosin feed (100 g/US ton of feed), and a 2nd group of 7 was given antibiotic-free feed. Samples were taken at 2- to 3-week intervals. For each pig, rectal, skin, and nasal swab samples were collected for enumeration of fecal streptococci and skin and nasal staphylococci. Percentages of macrolide resistant organisms of each group were tabulated on the basis of colony counts from antibiotic free and erythromycin-containing plates. After the introduction of tylosin into the feed of 1 group, a clear difference between the 2 groups with respect to the macrolide resistance of their gram-positive microflora was observed. The data indicate that tylosin feeding results in an increase in macrolide resistance of the bacterial flora of pigs.     

Pathogenicity of a Strain of H5N6 Subtype Avian Influenza Virus in Ducks and Mice

To investigate the pathogenicity of A/Hero/Guangdong/C1/2013(H5N6), an AIV strain isolated from Heron on ducks and mice, pathogenicity of this new virus strain and changing of histopathology as well as a preliminary study on its biological characteristics were studied by virus challenges test via intranasal and eye-drop and in chicken via jugular vein injection.Results showed that the EID₅₀ of this strain of virus was 10^-8.16/0.1 mL in embryonated chicken eggs and the intravenous inoculation of pathogenic index (IVPI) was 2.76.In ducks and mice, the 50% lethal doses (LD₅₀) of it were determined to be 10^-4.0/0.2 mL and 10^-4.67/0.05 mL, respectively.Symptoms of infection included loss of appetite, depression, swollen head and tears after being infected with 10⁶ EID₅₀ per duck by intranasal and eye-drop administration.Most of ducks died 4 to 7 days post-infection, liver, lung and kidney still eliminated toxicants at day 7 post-infection.Anatomy showed symptoms of pericardial effusion, pulmonary congestion and kidney enlargement, while pathological section showed pathological change like karyopycnosis and inflammatory cell infiltration in heart, liver, kidney and spleen.Mice developed symptoms of infection like loss of appetite, depression, shaggy coat and ruffled coat after being infected with 5×10⁵ EID₅₀ per mouse by intranasal and eye-drop administration.Most of the infected mice died 5 to 7 days post-infection and only liver still eliminated toxicants at day 7 post-infection.Although organ anatomy showed no obvious pathological changes, pathological section showed pathological changes like karyopycnosis and inflammatory cell infiltration in heart, kidney and lung.Our research demonstrated that this H5N6 subtype AIV had a strong pathogenicity and could be defined as a highly pathogenic AIV strain as its IVPI was greater than 1.2.Our work laid a theory foundation for study, prevention and control of H5N6 subtype AIV.     

Pharmacokinetics of tilmicosin in equine tissues and plasma

The macrolide antibiotic tilmicosin has potential for treating bacterial respiratory tract infections in horses. A pharmacokinetic study evaluated the disposition of tilmicosin in the horse after oral (4 mg/kg) or subcutaneous (s.c.) (10 mg/kg) administration. Tilmicosin was not detected in equine plasma or tissues after oral administration at this dose. With s.c. injection, tilmicosin concentrations reached a maximum concentration of approximately 200 ng/mL in the plasma of the horses. Tilmicosin concentrations in plasma persisted with a mean residence time (MRT) of 19 h. Maximum tissue residue concentrations (C(max)) of tilmicosin measured in equine lung, kidney, liver and muscle tissues after s.c. administration were 2784, 4877, 1398, and 881 ng/g, respectively. The MRT of tilmicosin in these tissues was approximately 27 h. Subcutaneous administration of tilmicosin resulted in severe reactions at the injection sites.     

动物专用大环内酯类新药——泰拉霉素

泰拉霉素是动物专用的新型大环内酯类抗生素,国内已批准用于猪呼吸系统疾病的防治。泰拉霉素的药动学特性优良,吸收快,达峰时间短,生物利用度高,在肺中可达到很高的组织浓度,消除半衰期长,药效持久。单次肌注或皮下给药即能提供全程的治疗,在兽医临床具有广阔的应用前景。本文综述了泰拉霉素的理化性质、作用机理、抗菌活性、药动学、药效学、不良反应及残留,为该药在兽医临床的应用提供参考资料。     

Tilmicosin as a single injection treatment for respiratory disease of feedlot cattle

Tilmicosin, a new semi-synthetic macrolide antibiotic, was evaluated in eight field trials as a single subcutaneous injection at dosages of 0 (placebo), 5, 10 and 20 mg/kg for the treatment of naturally occurring respiratory disease in feedlot cattle. Animals for these trials were selected from large groups of recently-shipped feeder cattle at the time clinical signs of respiratory disease and body temperature of 40.6°C or higher were observed. Treated animals were evaluated daily for 10 days and finally at day 28. Each animal was weighed on the first day and again on day 28. Animals that died were necropsied. All treatment dosages were effective in significantly lowering mortality, improving weight gains, lowering body temperature, and reducing the severity of clinical signs when compared to the placebo-treated controls. Body temperature was the only variable with statistically significant differences among the dose levels.     

Primary infection protects pigs against re-infection with Lawsonia intracellularis in experimental challenge studies

In two separate trials pigs were experimentally infected with Lawsonia intracellularis at 5-6 weeks of age followed by antibiotic treatment and resolution of the primary infection and then re-inoculated at 12-13 weeks of age. A treatment-control group of pigs received the primary infection and antibiotic treatment only, and served as control for the antibiotic treatment of the primary infection. A challenge-control group of pigs received the second inoculation dose only at 12-13 weeks of age to control infectivity of the challenge-dose and susceptibility of pigs to L. intracellularis at this age. Pigs were monitored for shedding of L. intracellularis in faeces by PCR, and for the development of antibodies and responses of acute phase proteins in serum. The presence of L. intracellularis antigen in the intestinal mucosa was examined in post mortem samples by immunohistochemistry. In both trials primary infected pigs were protected from infection after challenge inoculation as evidenced by absence of faecal shedding of L. intracellularis, lack of changes in acute phase protein concentrations after challenge and with low levels of bacterial antigen in the intestinal mucosa of re-inoculated pigs comparable to that of the treatment-control pigs. In contrast, challenge-control pigs shed L. intracellularis in faeces, had L. intracellularis antigen extensively present within all layers of the intestinal mucosa and developed a significant acute phase protein response in serum after the experimental infection. The acute phase protein response to L. intracellularis infection was detected as an increased rise in the serum concentrations of C-reactive protein and haptoglobin from day-6 post infection, and increased serum concentrations of haptoglobin were generally seen 2-3 weeks after inoculation both at 5-6 and 12-13 weeks of age. In conclusion substantial protection against L. intracellularis infection was found in the re-inoculated pigs in contrast to the development of infection in age-matched control pigs. The acute phase protein responses reflected both the observed protection against L. intracellularis infection upon secondary challenge and that increased resistance to the infection develops with age.     

Cisplatin for treatment of transitional cell and squamous cell carcinomas in dogs

Thirteen dogs with tumors were treated with monthly infusions of cisplatin. Complete responses were not observed. Of 8 dogs with urinary tract transitional cell carcinomas, 1 (12.5%) had a partial response of 31 weeks' duration, and 4 (50%) had stable disease for 12, 30, 32, and 34 weeks. Three (60%) of 5 dogs with head and neck squamous cell carcinomas had partial responses for 2, 10, and 15 weeks. All 13 dogs were evaluated for signs of toxicosis. Transient episodes of vomiting were recorded for 7 dogs (54%), and 2 dogs (15%) had mild thrombocytopenia. Although renal function gradually decreased in 2 dogs (15%), none of the dogs had an episode of acute renal failure attributable to cisplatin. These findings suggest that cisplatin may be a safe and potentially effective agent for treatment of transitional cell and squamous cell carcinomas in dogs.     

Standardized exercise test and daily heart rate responses of thoroughbreds undergoing conventional race training and detraining

Ten healthy sedentary male Thoroughbreds with previous race training experience were studied for 14 weeks. Horses were trained for 9 weeks, using a program designed after those used commonly in the United States. Horses were trained conventionally by slow trotting (250 m/min) for 2 weeks and galloping (390 to 450 m/min) for 4 weeks, followed by 3 weeks of galloping (440 to 480 m/min) and intermittent sprinting exercises (breezes) at distances between 600 and 1,000 m (900 to 950 m/min). The horses were then pasture rested for 5 weeks. A standardized exercise test (SET) involving an 800-m gallop at 800 m/min was administered before and after the 9-week training period and after the 5-week detraining period. Heart rate (HR) was monitored during exercise and at standardized intervals after exercise for 60 minutes. Venous blood for determination of plasma lactate concentration was obtained at 5 minutes after exercise. Heart rate was monitored daily at rest, during exercise, and through the first 60 minutes of recovery. Venous plasma samples (for lactate determination) were obtained 5 minutes after the sprinting exercises. Horses were observed daily before exercise for signs of lameness and were not allowed to train if lame. Differences after 9 weeks' training were seen in the SET recovery HR at 0.5 through 5 minutes after exercise (P less than 0.05 to P less than 0.01). Differences after detraining were seen in the SET recovery HR at 40 and 60 minutes after exercise (P less than 0.05 to P less than 0.01). Neither training nor detraining resulted in differences in plasma lactate concentration after the SET gallop.(ABSTRACT TRUNCATED AT 250 WORDS)     

维生素K_3对五龙鹅生长性能、屠宰性能及养分表观利用率的影响

本试验旨在研究饲粮中维生素K3添加水平对五龙鹅生长性能、屠宰性能及养分表观利用率的影响。试验分为2个阶段。1~4周龄阶段,选用1日龄五龙鹅360只,随机分为6个组,每个组6个重复,每个重复10只鹅。Ⅰ组为对照组,饲喂基础饲粮(维生素K3含量1.23 mg/kg),Ⅱ~Ⅵ组在基础饲粮中分别添加1、2、4、8、16 mg/kg的维生素K3。5~16周龄阶段,选用28日龄五龙鹅324只,随机分为6个组,每个组6个重复,每个重复9只鹅。A组为对照组,饲喂基础饲粮(维生素K3含量1.18 mg/kg),B~F组在基础饲粮中分别添加2、4、8、16、32 mg/kg的维生素K3。试验期16周。结果表明:1)经回归分析得出,1~4周龄阶段五龙鹅饲粮中添加4.81 mg/kg维生素K3,平均日增重最大;5~16周龄阶段饲粮中添加11.59 mg/kg维生素K3,平均日增重最大。2)与对照组相比,1~4周龄阶段,饲粮中添加4 mg/kg维生素K3能显著或极显著提高鹅的全净膛率和腹脂率(P0.05或P0.01);5~16周龄阶段,饲粮中添加8 mg/kg维生素K3能显著或极显著提高屠宰率、半净膛率、全净膛率和腿肌率(P0.05或P0.01)。3)与对照组相比,5~16周龄阶段,饲粮中添加8 mg/kg维生素K3能极显著提高钙的表观利用率(P0.01),显著提高干物质、粗蛋白质、粗脂肪、中性洗涤纤维、酸性洗涤纤维和磷的表观利用率(P0.05)。由此可见,本试验条件下,1~4周龄和5~16周龄五龙鹅饲粮中维生素K3适宜添加水平分别为4.81和11.59 mg/kg。     

Pharmacokinetic interpretation of erythromycin and tylosin activity in serum after intravenous administration of a single dose to cows.

The distribution and elimination kinetics of erythromycin and tylosin, which are macrolide antibiotics, were studied in healthy cows. A single dose (12-5 mg/kg) of drug was administered as an intravenous bolus, and blood samples were collected at precisely timed intervals. The standard cylinder plate bioassay method using Sarcina lutea as test organism was employed to determine antibiotic activity in the serum. The results suggested that these drugs are distributed in at least two kinetically distinct body compartments. By use of established mathematical techniques, values were assigned to the individual rate constants controlling distribution between the central and peripheral compartments and to the rate constant controlling overall elimination (beta) of each drug from the body. The calculated overall tissue to serum drug level ratios (k12/k21) after apparent distribution equilibrium was attained were 2-28 and 2-05 for erythromycin and tylosin, respectively. The half-life (mean+/-SD) of erythromycin was 3-16 h+/-0-44, while that of tylosin was 1-62 h+/-0-17. The total body clearance (ml/kg/min) values were 2-88+/-0-47 for erythromycin and 7-8+/-2-95 for tylosin. Analogue computer simulated curves of the antibiotic levels in the central and tissue compartments as wel as an elimination curve were generated. The tissue level of erythromycin reached a peak of 43 per cent of the dose at 67 min. At 6 h, the percentages of the dose of erythromycin in the central and tissue compartments and eliminated were 6, 19 and 75, respectively. The peak level of tylosin in the tissue compartment (26-5 per cent of the dose) was present at 30 min. At 4 h, 1 and 5 per cent of the dose were contained in the central and peripheral compartments, respectively, while 94 per cent had been eliminated. This single dose study provides information which is essential for the design of a satisfactory dosage regimen.     

Masked, controlled study to investigate the efficacy of a Staphylococcus intermedius autogenous bacterin for the control of canine idiopathic recurrent superficial pyoderma

A masked, controlled study was designed to investigate the clinical efficacy of a staphylococcal autogenous bacterin for the control of canine idiopathic recurrent pyoderma (IRP). Ten dogs with at least three prior episodes of recurrent superficial pyoderma were recruited. All were screened and found to be free of ectoparasitic and fungal disease and failed to respond favourably to a dietary trial. Those exhibiting signs of pruritus responded completely to antibacterial therapy. Haematological and biochemical parameters were generally unremarkable and all dogs were euthyroid. Staphylococcus intermedius cultures from lesions were used to produce an autogenous bacterin for each animal. A numerical 'lesion score' was allocated and dogs were randomly divided into two groups of five (groups 1 and 2). Both groups received a 4-week course of antibiotic; group 1 also received concurrent s/c injections of bacterin, which continued until week 10. Group 2 received no additional therapy. All dogs were re-examined and rescored at weeks 5 and 10 and repeat blood samples were submitted at week 10 to screen for adverse effects. Comparison of scores at week 0 and week 5 (Mann-Whitney U-test) revealed no significant differences between the groups. At week 10, group 2 (control group) individual lesion scores were significantly higher compared with the group receiving bacterin (P < 0.05) and there was a significantly greater increase in the sum of the individual lesion scores for group 2 compared with group 1, from week 5 to week 10 (P < 0.05). No adverse reactions to bacterin therapy were detected. These results suggest that autogenous bacterins may provide an alternative, safe, effective method for the control of canine IRP. Further studies using larger groups of dogs and for a longer follow-up period are now warranted.     

The influence of age on the response of ring-necked pheasants to infection with marble spleen disease virus.

Ring-necked pheasants that were negative for maternal antibody against type II avian adenoviruses were orally inoculated with 5.0 x 10(2) tissues-culture-infective doses of marble spleen disease (MSD) virus at 1-week intervals through 6 weeks of age, and at 9 and 13 weeks of age. Groups of four virus-inoculated birds and two control birds were necropsied at 4, 6, 8, and 10 days postinoculation, and the spleens were evaluated for gross and microscopic lesions. No lesions consistent with MSD were present in birds inoculated at 1, 2, 3, or 4 weeks of age. A single bird in the group inoculated at 5 weeks of age had gross and microscopic lesions of MSD. Five birds in the group inoculated at 6 weeks of age had lesions of MSD. The patterns of lesion development in the 6-week-old birds were similar to those produced in the 9- and 13-week-old birds inoculated with MSD virus. The reason for the lack of gross or microscopic lesion development during the first 4 weeks of life is unknown.